These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 26621566

  • 1. Relationship Among Strongyloides stercoralis Infection, Human T-Cell Lymphotropic Virus Type 1 Infection, and Cancer: A 24-Year Cohort Inpatient Study in Okinawa, Japan.
    Tanaka T, Hirata T, Parrott G, Higashiarakawa M, Kinjo T, Kinjo T, Hokama A, Fujita J.
    Am J Trop Med Hyg; 2016 Feb; 94(2):365-370. PubMed ID: 26621566
    [Abstract] [Full Text] [Related]

  • 2. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T, Uchima N, Kishimoto K, Zaha O, Kinjo N, Hokama A, Sakugawa H, Kinjo F, Fujita J.
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [Abstract] [Full Text] [Related]

  • 3. Epidemiological aspects of Strongyloides stercoralis infection in Okinawa, Japan.
    Arakaki T, Kohakura M, Asato R, Ikeshiro T, Nakamura S, Iwanaga M.
    J Trop Med Hyg; 1992 Jun; 95(3):210-3. PubMed ID: 1597879
    [Abstract] [Full Text] [Related]

  • 4. Correlation between human T cell lymphotropic virus type-1 and Strongyloides stercoralis infections and serum immunoglobulin E responses in residents of Okinawa, Japan.
    Hayashi J, Kishihara Y, Yoshimura E, Furusyo N, Yamaji K, Kawakami Y, Murakami H, Kashiwagi S.
    Am J Trop Med Hyg; 1997 Jan; 56(1):71-5. PubMed ID: 9063365
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Treatment of strongyloidiasis in HTLV-1 and Strongyloides stercoralis coinfected patients is associated with increased TNFα and decreased soluble IL2 receptor levels.
    Salles F, Bacellar A, Amorim M, Orge G, Sundberg M, Lima M, Santos S, Porto A, Carvalho E.
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):526-9. PubMed ID: 23843560
    [Abstract] [Full Text] [Related]

  • 7. Implication of HTLV-I infection, strongyloidiasis, and P53 overexpression in the development, response to treatment, and evolution of non-Hodgkin's lymphomas in an endemic area (Martinique, French West Indies).
    Agapé P, Copin MC, Cavrois M, Panelatti G, Plumelle Y, Ossondo-Landeau M, Quist D, Grossat N, Gosselin B, Fenaux P, Wattel E.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr 01; 20(4):394-402. PubMed ID: 10096585
    [Abstract] [Full Text] [Related]

  • 8. Fatal outcome in a patient under immunosuppressant therapy infected with human T-lymphotropic virus type 1 (HTLV-1), cytomegalovirus (CMV) and Strongyloides stercoralis: a case report.
    Ashida C, Kinoshita K, Nozaki Y, Funauchi M.
    BMC Infect Dis; 2020 Jul 02; 20(1):470. PubMed ID: 32615937
    [Abstract] [Full Text] [Related]

  • 9. Immunoepidemiologic studies of Strongyloides stercoralis and human T lymphotropic virus type I infections in Jamaica.
    Robinson RD, Lindo JF, Neva FA, Gam AA, Vogel P, Terry SI, Cooper ES.
    J Infect Dis; 1994 Mar 02; 169(3):692-6. PubMed ID: 8158055
    [Abstract] [Full Text] [Related]

  • 10. Is the prevalence of HTLV-1 infection higher in Strongyloides carriers than in non-carriers?
    Arakaki T, Asato R, Ikeshiro T, Sakiyama K, Iwanaga M.
    Trop Med Parasitol; 1992 Sep 02; 43(3):199-200. PubMed ID: 1470843
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Coinfection by Strongyloides stercoralis in blood donors infected with human T-cell leukemia/lymphoma virus type 1 in São Paulo City, Brazil.
    Chieffi PP, Chiattone CS, Feltrim EN, Alves RC, Paschoalotti MA.
    Mem Inst Oswaldo Cruz; 2000 Sep 02; 95(5):711-2. PubMed ID: 10998221
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Predictive markers for development of strongyloidiasis in patients infected with both Strongyloides stercoralis and HTLV-1.
    Satoh M, Kiyuna S, Shiroma Y, Toma H, Kokaze A, Sato Y.
    Clin Exp Immunol; 2003 Sep 02; 133(3):391-6. PubMed ID: 12930366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.